Skip Nav Destination
Issues
Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism.
Diabetes April 2000, Vol.49, 527-531. doi:https://doi.org/10.2337/diabetes.49.4.527
Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
Diabetes April 2000, Vol.49, 539-547. doi:https://doi.org/10.2337/diabetes.49.4.539
Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets.
Diabetes April 2000, Vol.49, 555-561. doi:https://doi.org/10.2337/diabetes.49.4.555
Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity.
Diabetes April 2000, Vol.49, 562-570. doi:https://doi.org/10.2337/diabetes.49.4.562
Validation of methods for measurement of insulin secretion in humans in vivo.
Diabetes April 2000, Vol.49, 580-588. doi:https://doi.org/10.2337/diabetes.49.4.580
Genetic modifiers of the insulin resistance phenotype in mice.
Diabetes April 2000, Vol.49, 589-596. doi:https://doi.org/10.2337/diabetes.49.4.589
Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors.
Diabetes April 2000, Vol.49, 597-602. doi:https://doi.org/10.2337/diabetes.49.4.597
Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM.
Diabetes April 2000, Vol.49, 603-610. doi:https://doi.org/10.2337/diabetes.49.4.603
Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.
Diabetes April 2000, Vol.49, 611-617. doi:https://doi.org/10.2337/diabetes.49.4.611
v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.
Diabetes April 2000, Vol.49, 618-625. doi:https://doi.org/10.2337/diabetes.49.4.618
Can clinical factors estimate insulin resistance in type 1 diabetes?
Diabetes April 2000, Vol.49, 626-632. doi:https://doi.org/10.2337/diabetes.49.4.626
Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation.
Diabetes April 2000, Vol.49, 640-646. doi:https://doi.org/10.2337/diabetes.49.4.640
Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients.
J W Ryder; J Yang; D Galuska; J Rincón; M Björnholm; A Krook; S Lund; O Pedersen; H Wallberg-Henriksson; J R Zierath; G D Holman
Diabetes April 2000, Vol.49, 647-654. doi:https://doi.org/10.2337/diabetes.49.4.647